Four New Products Set to Captivate U.S. Consumers The ... MEDIPEEL is the flagship brand of SKINIDEA, which is under MDP Holdings (CEO Michael Chung), a portfolio company of Morgan Stanley ...

Medexus Pharmaceuticals (TSE:MDP – Free Report) had its price objective increased by Stifel Nicolaus from C$4.15 to C$4.50 in a research report released on Tuesday morning,BayStreet.CA reports.

Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report) hit a new 52-week high during mid-day trading on Wednesday after Stifel Nicolaus raised their price target on the stock from C$4.15 to C$4.50.

MEDIPEEL is the flagship brand of SKINIDEA, which is under MDP Holdings (CEO Michael Chung), a portfolio company of Morgan Stanley PE Asia (MSPEA). SKINIDEA exports to over 75 countries worldwide, ...